Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma
- PMID: 30030906
- PMCID: PMC6143931
- DOI: 10.1002/cam4.1679
Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma
Abstract
Carbon ion radiotherapy is known for its high-precision dose distribution and high biological effectiveness. We evaluated the results of carbon ion radiotherapy in 128 patients with unresectable localized axial soft tissue sarcoma at a single institution. The patients' median age was 54 years, and the median follow-up period was 49.4 (range 6.4-146.4) months. The median tumor volume was 356 cm3 . The 5-year local control, overall survival, and disease-free survival rates were 65%, 46%, and 39%, respectively. In the univariate analysis, tumor volume, local control, and incidences of metastases were significantly related to overall survival. In the multivariate analysis, tumor volume and local control were significantly related to overall survival. We did not find any factors related to local control. Five patients required surgical intervention because of adverse events in the bones. Carbon ion radiotherapy may be a treatment option for unresectable axial soft tissue sarcoma.
Keywords: carbon ion radiotherapy; charged particle therapy; radiotherapy; soft tissue sarcoma.
© 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures



References
-
- Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res. 2004;419:165‐172. - PubMed
-
- Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679‐1689. - PubMed
-
- O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft‐tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235‐2241. - PubMed
-
- Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case‐control, propensity score‐matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17(7):966‐975. - PubMed
-
- Smith KB, Indelicato DJ, Knapik JA, et al. Definitive radiotherapy for unresectable pediatric and young adult nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer. 2011;57(2):247‐251. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical